Akonni, Seegene Enter Nonexclusive Licensing Agreement
The agreement brings together Seegene’s Dual Priming Oligo multiplex PCR technology and Akonni’s TruArray gel-drop microarray technology.
Read MoreSearch Results for: liver disease
News Story #15316
Posted by Clinical Lab Products | Apr 6, 2011 | Cancer |
Amgen Cancer Drug Fails in Phase 3 Study Thousand Oaks, Calif — Amgen, Cambridge, Mass-based Millennium: The Takeda Oncology Company, and Takeda Pharmaceutical Co, Osaka, Japan, announced the top-line results from the pivotal
Read MorePartnership Offers Breakthrough Diagnostic Assay
Posted by Clinical Lab Products | Mar 13, 2011 | Miscellaneous |
Health Diagnostic Laboratory joins Gamma Therapeutics to deliver novel test for heart attack, stroke risks.
Read MoreVical, UW Receive Patent For Herpes Simplex Vaccine
Posted by Clinical Lab Products | Mar 13, 2011 | Infectious Diseases, Sexually Transmitted Diseases |
The new patent covers DNA vaccines containing the HSV-2 UL49 gene, which encodes the VP22 tegument protein, formulated with or without Vical’s Vaxfectin adjuvant.
Read MorePhase 2 Trial of IPI-926 In Pancreatic Cancer Treatment Initiated
Posted by Clinical Lab Products | Mar 13, 2011 | Cancer, Miscellaneous, Pancreatic |
Smoothened inhibition with IPI-926 represents a potentially new approach to addressing difficult-to-treat cancer.
Read More